Thanks to rising alcohol and drug testing, the global immunoassay market is growing at a fast pace over the next few years. Some of the key factors estimated for ensuring the development of the immunoassay market over the coming years are the technological developments in this field, together with the advent of new automated systems. The report provides analysis of global Immunoassay market for the period 2016-2026, wherein 2018 to 2026 is the forecast period and 2017 is considered as the base year. According to Acumen Research and Consulting, the global Immunoassay market is expected to grow at significant CAGR around 4.9% throughout the forecast period and reach around US$ 26.1 billion by 2026.
The major factors that are expected to contribute to a market development in the coming years are a significant increase for infectious and chronic diseases and the increase in the use of immunoassays in oncology. It is estimated that the increased geriatric population and technological progress in this area will speed up the overall market growth in the next several years. In the future, a further factor that will lead to potential opportunities for growth are the high development of biopharmaceutical and biotechnological industries.
On the flip side the unfavorable reimbursement environment is estimated to limit the development of the global immunoassay market in the coming years, and strict provisions and regulations relating to approvals of immunoassay consumables and tools. Furthermore, growing complexities are expected to reduce overall market developments in the next few years when performing diagnostic tests. The growing opportunities in the developing countries are nevertheless predicted to secure market growth in the next few years.
North America is anticipated to govern the Immunoassay Market
In recent years, the North American immunoassay market has held an enormous market share and is likely to continue to be the same for some years to come. In the coming years, the high number of research projects and the existing well-established healthcare infrastructures are projected to speed up the development of the North American immunoassay market. The growth of this region will be expected to be accelerated in the coming years as geriatric populations and the development of the biotechnology and pharmaceutical industries increase. In addition, the growth of Asia-Pacific in the future will be promising, thanks to the increasing number of In recent years, the North American immunoassay market has held an enormous market share and is likely to continue to be the same for some years to come.
Immunoassay Market by Technology
Immunoassay Market by Product
Immunoassay Market by Application
Immunoassay Market by End-Use
Global Immunoassay Market, by Geography
The market research study on “Immunoassay Market (By Technology: Enzyme Immunoassay (EIA) [Fluorescence Immunoassays (FIA), Chemiluminescence Immunoassays (CLIA)], Radioimmunoassay (RIA), Rapid test, Others; By Product: Analyzers/instruments [Closed ended systems, Open ended systems], Reagents & kits, Software & services; By Application: Endocrinology, Therapeutic drug monitoring, Autoimmune diseases, Infectious disease testing, Cardiology, Others; By End-Use: Hospitals, Pharmaceutical and biotech companies, Clinical laboratories, Academic research centers, Blood banks, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026” offers detailed insights on global Immunoassay market segments with market dynamics and their impact.
The key players of the market are Dickinson & Company; Becton, Thermo Fisher Scientific, Inc.; BioMérieux; Siemens Healthineers; Abbott laboratories; Roche Diagnostics; Sysmex Corporation; Danaher Corporation; Ortho Clinical Diagnostics; and Quidel Corporation.
According to Acumen Research and Consulting, the global Botulinum Toxin market is expected to grow at noteworthy CAGR around 8 % throughout the forecast period and reach around US$ 7.5 billion by 2026. The imperative quality needs and fresh apps are sustaining competition in the worldwide industry of botulinum toxins. Most businesses invest in studies to identify fresh apps which c
Introduction According to Acumen Research and Consulting, the global market of Surgical Instrument Tracking Systems is expected to grow at noteworthy CAGR around 18.6 % throughout the forecast period and reach around US$ 500 million by 2026. Surgical instruments have long been accessible for use in healthcare. Systems for the mo
Introduction According to Acumen Research and Consulting, the global Aesthetic Medicine market is expected to grow at noteworthy CAGR around 8.5 % throughout the forecast period and reach around US$ 16.3 billion by 2026. Aesthetic Medicines is a clinical subspecialty and field for scientific research that includes all kinds of m
Introduction: Viscosupplementation is a treatment that aids in diminishing joint agony and improves the practical state of the osteoarthritic joint. It includes the infusion of a thick liquid called hyaluronate into the knee. Hyaluronic corrosive is found in the gooey synovial liquid that greased up the ligament surfaces and shields the joint from stun. This corrosive is a versatil
Introduction: Smart home healthcare is intended to help in treatment determination, care in the home. It helps in improving the correspondence between the parental figures and healthcare suppliers. Also, numerous wellbeing conditions, particularly incessant illnesses, could be checked and treated in a home outfitted with fundamental smart home items. The global smar
Introduction: The global hyaluronic acid market size is expected to reach 11.07 billion by the end of year 2026. The market is estimated to grow at a CAGR of 6.6% over the forecast period 2019 to 2026. Hyaluronic acid, otherwise called hyaluronan, is a reasonable, gooey substance that is normally delivered by your body. Its biggest measures are found in you